Eton Pharmaceuticals (ETON) Operating Income (2019 - 2025)
Historic Operating Income for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to -$1.4 million.
- Eton Pharmaceuticals' Operating Income fell 36778.0% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year increase of 4866.83%. This contributed to the annual value of -$2.6 million for FY2024, which is 11786.91% down from last year.
- Latest data reveals that Eton Pharmaceuticals reported Operating Income of -$1.4 million as of Q3 2025, which was down 36778.0% from -$1.5 million recorded in Q2 2025.
- In the past 5 years, Eton Pharmaceuticals' Operating Income registered a high of $5.4 million during Q1 2021, and its lowest value of -$5.8 million during Q3 2021.
- In the last 5 years, Eton Pharmaceuticals' Operating Income had a median value of -$1.3 million in 2022 and averaged -$886947.4.
- Per our database at Business Quant, Eton Pharmaceuticals' Operating Income skyrocketed by 38977.61% in 2023 and then crashed by 36778.0% in 2025.
- Quarter analysis of 5 years shows Eton Pharmaceuticals' Operating Income stood at $1.3 million in 2021, then fell by 19.18% to $1.1 million in 2022, then crashed by 287.66% to -$2.0 million in 2023, then skyrocketed by 131.56% to $629000.0 in 2024, then crashed by 316.69% to -$1.4 million in 2025.
- Its Operating Income was -$1.4 million in Q3 2025, compared to -$1.5 million in Q2 2025 and -$470000.0 in Q1 2025.